Kenneth J. Hillan
CIK 1600359 · View on SEC EDGAR ↗
Insider
First SEC filing: Dec. 23, 2022 · Latest: Dec. 23, 2022
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 2 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 7, 2023 | ZYME | A | 37,000 | — | — | 37,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Dec. 21, 2022 | ZYME | A | 25,000 | — | — | 25,000 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Dec. 7, 2023 | ZYME | Stock Option (Right to Buy) | Common Stock (37,000) | $9.55 | Dec. 6, 2033 | 37,000 | Acquired |
| Dec. 21, 2022 | ZYME | Stock Option (Right to Buy) | Common Stock (25,000) | $8.75 | Dec. 20, 2032 | 25,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).